14 insiders reported 232 Form 4 transactions for JOHNSON & JOHNSON (JNJ) over the past 18 months (most recent 2026-06-12). Recent activity: Wengel Kathryn E (EVP, Chief TO and Risk Officer) Sell 10,000 shares, Wengel Kathryn E (EVP, Chief TO and Risk Officer) Buy 10,000 shares, Decker Robert J (VP Corporate Controller) Buy 4,075 shares, Decker Robert J (VP Corporate Controller) Sell 4,075 shares, Schmid Timothy (EVP, WW Chair, MedTech) Sell 1,322 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-12 | Wengel Kathryn E | EVP, Chief TO and Risk Officer | Sell | 10,000 | $2.4M |
| 2026-06-12 | Wengel Kathryn E | EVP, Chief TO and Risk Officer | Buy | 10,000 | $1.2M |
| 2026-03-03 | Decker Robert J | VP Corporate Controller | Buy | 4,075 | $471,355 |
| 2026-03-03 | Decker Robert J | VP Corporate Controller | Sell | 4,075 | $1.0M |
| 2026-02-23 | Schmid Timothy | EVP, WW Chair, MedTech | Sell | 1,322 | $324,763 |
| 2026-02-18 | Taubert Jennifer L | EVP, WWC. Innovative Medicine | Sell | 945 | $230,060 |
| 2026-02-18 | Taubert Jennifer L | EVP, WWC. Innovative Medicine | Sell | 409 | $100,021 |
| 2026-02-18 | Taubert Jennifer L | EVP, WWC. Innovative Medicine | Buy | 27,412 | $0 |
| 2026-02-18 | Taubert Jennifer L | EVP, WWC. Innovative Medicine | Sell | 13,547 | $3.3M |
| 2026-02-18 | Taubert Jennifer L | EVP, WWC. Innovative Medicine | Buy | 1,594 | $0 |
| 2026-02-18 | Taubert Jennifer L | EVP, WWC. Innovative Medicine | Sell | 816 | $198,655 |
| 2026-02-18 | Taubert Jennifer L | EVP, WWC. Innovative Medicine | Buy | 1,847 | $0 |
| 2026-02-18 | Taubert Jennifer L | EVP, WWC. Innovative Medicine | Buy | 1,302 | $0 |
| 2026-02-18 | Duato Joaquin | CEO and Chairman of the Board | Buy | 3,469 | $0 |
| 2026-02-18 | Duato Joaquin | CEO and Chairman of the Board | Sell | 989 | $241,860 |
| 2026-02-18 | Duato Joaquin | CEO and Chairman of the Board | Buy | 73,054 | $0 |
| 2026-02-18 | Duato Joaquin | CEO and Chairman of the Board | Sell | 31,679 | $7.7M |
| 2026-02-18 | Duato Joaquin | CEO and Chairman of the Board | Buy | 3,682 | $0 |
| 2026-02-18 | Wengel Kathryn E | EVP, Chief TO and Risk Officer | Sell | 6,414 | $1.6M |
| 2026-02-18 | Duato Joaquin | CEO and Chairman of the Board | Buy | 4,505 | $0 |
| 2026-02-18 | Duato Joaquin | CEO and Chairman of the Board | Sell | 1,960 | $477,162 |
| 2026-02-18 | Wengel Kathryn E | EVP, Chief TO and Risk Officer | Buy | 651 | $0 |
| 2026-02-18 | Wengel Kathryn E | EVP, Chief TO and Risk Officer | Sell | 217 | $53,067 |
| 2026-02-18 | Wengel Kathryn E | EVP, Chief TO and Risk Officer | Buy | 13,706 | $0 |
| 2026-02-18 | Duato Joaquin | CEO and Chairman of the Board | Sell | 1,602 | $390,007 |
Source: SEC Form 4 filings · as of 2026-06-12